Health ResearchTx

Health ResearchTx (HRTx) is a biotechnology company focused on the discovery and development of small molecule modulators of the transsulfuration pathway. The company specifically targets enzymes such as cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE) to treat conditions associated with hydrogen sulfide dysregulation and homocysteine metabolism. Their lead programs aim to address rare metabolic disorders like homocystinuria and complex conditions including Down syndrome and various cancers. By leveraging expertise in sulfur biochemistry, HRTx seeks to develop first-in-class therapies for diseases with significant unmet medical needs.